DNA & RNA

9 FAQs About Charles River's Service Offerings

Experience NVIGEN's Magnetic Nanobeads Capture Technology

Industrializing the Discovery of Programmable Medicines With Messenger Bio

Discover Cutting-Edge Biotech Tools: Luna Nanotech's Top-Selling Molecular Biology Kits and Nanoparticles

mRNA: The Key to Therapeutics?

Chronological Age vs Biological Age: Can Aging be Reversed?

High-Throughput-qPCR and Transcriptomics: Powering the Next Generation of Drug Discovery

Scaling AAV9 Manufacturing: A Blueprint for Clinical-Grade Gene Therapy Production

Epigenomics at 360 in Liquid Biopsy: Approaches and Case Studies for Biomarker Discovery and Drug Development

Gene-Agnostic Gene Therapy to Preserve Vision

In Vivo panCAR Therapy Using Circular RNA for the Treatment of Autoimmune Disease

Enhance Your Tissue Processing Efficiency with the STEMprep Tissue Dissociator

Reprogramming Mouse Fibroblasts Into Induced Cardiomyocytes: Age-Related, Metabolic, and Epigenetic Barriers

CRISPR Gene Editing in Primary T Cells: A Case Study in the Fight Against HIV

Fresh or Cryopreserved Leukopaks? Assessing the Impact of Different Storage Conditions on Leukopak Stability

High-Quality Mobilized Leukopaks to Enhance Your Cell and Gene Therapy Research and Development

Arrayed CRISPR screening for phenotypic discovery at the MRC-AstraZeneca-University of Cambridge Joint Functional Genomics Screening Laboratory (FGSL)

Licensing Biological Materials: Crucial Considerations for Preclinical Researchers

A New Approach to Vector-Free CRISPR Editing Starting From Single Cells

Hematopoietic Stem Cell Fitness and Function During Sickle Cell Disease

Developing a Novel Gene Therapy for Kcnv2 Retinopathy

How to Better Predict Potential Drug Interactions Early in the Discovery Process

How to Create CRISPR-Edited T Cells More Efficiently for Tomorrow's Cell Therapies

Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Genome Engineering

Developing Retinal Gene Therapy for Zellweger Spectrum Disorder (ZSD)

Creating Better Gene-Edited Cell Lines with the FAST-HDR System

Cardiovascular Regenerative Medicine: Deconstructing Regenerative Therapeutics

Integration of the HTG Transcriptome Panel into Preclinical and Clinical Programs to Drive Precision Medicine Research

Applications of Single-Cell Sequencing: Innovative and Tailor-Made Services

Optimizing CD34+ Cell Genome Editing for Efficiency and HSPC Maintenance

Spectronaut: Expand Biological Insights with DIA Proteomics

Restoring Vision - Optogenetic Gene Therapy Targeted at Human ON-Bipolar Cells

#ExpertAnswers: Jack Vanden Heuvel on Prediction Drug-Drug Interactions Early

#ExpertAnswers: Steven Loo-Yong-Kee on CRISPR-Edited T Cells

#ExpertAnswers: Sam Sternberg on Genome Engineering

#ExpertAnswers: Dudley Lamming on the Influence of Sex and Genetic Background on Diet

#ExpertAnswers: Rajendra Kumari and Gera Goverse on the Cancer Immunity Cycle

#ExpertAnswers: Oscar Perez Leal and Jon Weidanz on Gene Editing

#ExpertAnswers: Ejvind Mørtz on Protein Analysis

#ExpertAnswers: David Barefield on Atrial Dysfunction

#ExpertAnswers: Eduardo Marbán on Regenerative Cardiovascular Medicine

Industry Insights with Crown Bioscience: In Vitro Technologies for Studying the Cancer-Immunity Cycle

#ExpertAnswers: Peter Ansell and Marian Navratil on Gene Expression Profiling

#ExpertAnswers: Bastiaan Bijl and Dylan Mooijman on Single-Cell Sequencing

#ExpertAnswers: Marta Walasek and Danielle Nguyen Truong on Stem Cells

#ExpertAnswers: Anuj Kalsy and Robert Snyder On The Variant-Rich Biobank

#ExpertAnswers: Agenor Limon on the Electrophysiology of Human Native Receptors

#ExpertAnswers: Caroline Williams and Eric Riddell on Ecophysiology and Climate Change

#ExpertAnswers: Oliver Bernhardt and Andreas-David Brunner on Biological Insights with DIA Proteomics

#ExpertAnswers: Michael Czech on CRISPR-Enhanced Adipocyte Browning

#ExpertAnswers: Sharon Ladyman & Vicki Vieira-Potter on Metabolic Phenotyping

#ExpertAnswers: Lora Heisler on Obesity